# Vetherapy

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vetherapy

- Industry: Consumer Products
- Headquarters: San Francisco, US
- Website: www.vetherapy.pt
- Latest round: Seed (Jan 22, 2018)
- Investors on record: 2

## About

Vetherapy specializes in innovative stem cell therapies for pets, providing solutions that harness regenerative medicine to enhance the healing process of companion animals suffering from various diseases.Founded in 2015 in San Francisco, US, Vetherapy focuses on stem cell therapies for pets. The company was established by Fernanda Berti and Pedro Carvalho, who also serves as CEO. Vetherapy had a notable funding round in January 2018, raising an undisclosed amount in Seed funding from investors SOSV and IndieBio, marking it as a targeted investment opportunity. The company has conducted one total deal as of now.Vetherapy specializes in stem cell therapies specifically designed for pets, leveraging nearly two decades of research in regenerative medicine and tissue engineering. Their core offerings include stem cell-derived solutions aimed at addressing complex and challenging diseases in companion animals. The products are intended to facilitate natural healing processes in pets, enhancing recovery from conditions such as orthopedic injuries and degenerative diseases. The company serves a diverse customer base that includes veterinary clinics and pet healthcare providers, primarily in the North American and European markets. By collaborating with a multidisciplinary team of scientists, bioengineers, and veterinarians, Vetherapy has positioned itself to effectively tackle the challenges of pet healthcare with innovative, cost-efficient solutions.Vetherapy's revenue model is centered around providing specialized stem cell therapies through partnerships with veterinary clinics and direct sales to pet healthcare providers. Transactions are structured primarily as business-to-business interactions, where veterinary practices purchase treatments to offer to their clients. Specific pricing details for products and services are tied to the nature of treatments delivered, which may include flagship offerings such as their custom stem cell solutions and wound healing hydrogels. The company’s revenue generation strategy hinges on establishing long-term relationships with veterinary partners and ensuring that their innovative therapies are accessible to a broad range of end users. Through these channels, Vetherapy aims to expand its market reach and solidify its position in the burgeoning field of veterinary regenerative medicine.Vetherapy plans to utilize the funds raised in January 2018 to support the development of new stem cell therapy products aimed at enhancing treatment options for pets. The company is also targeting an expansion into new markets, particularly in Asia and Latin America, within the next three years. By implementing these strategies, Vetherapy aims to broaden its geographical reach and increase its market presence in the field of veterinary regenerative medicine.

## Funding rounds

- Seed, Jan 22, 2018 — SOSV, IndieBio

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed
- IndieBio (https://capitalatlas.ai/funds/indiebio) — Seed